Within the liver, the loss or downregulation of SPTBN1 expression promotes hepatocellular carcinoma—and other tumor progression—by interrupting the TGF-β pathway and enhancing the Wnt signaling pathway in mice [43] and humans [44]. Here, SPTBN1 is linked to neoplasm.